Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 456.95 |
| Open | 454.79 |
| Bid | 446.81 x 100 |
| Ask | 447.34 x 100 |
| Day's Range | 445.22 - 454.79 |
| 52 Week Range | 320.01 - 457.66 |
| Volume | |
| Avg. Volume | 1,043,306 |
| Market Cap | 115.319B |
| Beta (5Y Monthly) | 0.39 |
| PE Ratio (TTM) | 29.67 |
| EPS (TTM) | 15.06 |
| Earnings Date | Jul 30, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 467.71 |
GuruFocus.comInsider Selling: Director Bruce Sachs Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
On May 22, 2024, Bruce Sachs, Director at Vertex Pharmaceuticals Inc (NASDAQ:VRTX), executed a sale of 7,073 shares of the company.
Investor's Business DailyNew Pain Drug Could Be Big For Vertex Stock As Shares Score Breakout
Cystic fibrosis treatment leader Vertex scored a breakout from a cup base this week, just a few weeks after an earnings beat.
GuruFocus.comInsider Sale: CEO & President Reshma Kewalramani Sells 15,202 Shares of Vertex ...
On May 20, 2024, Reshma Kewalramani, CEO & President of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), executed a sale of 15,202 shares of the company, according to the SEC Filing.
© 2024 Yahoo. All rights reserved.